4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)Fátima Cardoso, E.P. Winer, Matti Aapro et al.|Annals of Oncology|2018Cited by 1.2k
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3M.P. Goetz, S. Johnston, M. Toi et al.|Annals of Oncology|2024Cited by 204